Finance

Lists
GMAB:CPH
Genmab A/S
DKK 2,317.00
+0.65%
(+15.00) 1D
9-р сарын 29, 17:00:00 (GMT+2)  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for GMAB...
Open
DKK 2,300.00
High
DKK 2,340.00
Low
DKK 2,295.00
Mkt. cap
143.90Т
Avg. vol.
108.07 мян
Volume
136.64 мян
52-wk high
DKK 2,340.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41 сая
No. of employees
3 мян
Open
DKK 2,300.00
High
DKK 2,340.00
Low
DKK 2,295.00
Mkt. cap
143.90Т
Avg. vol.
108.07 мян
Volume
136.64 мян
52-wk high
DKK 2,340.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41 сая
No. of employees
3 мян
News stories
From web sources and news partners
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12 мян
Founded1998 оны 6-р сарын 11
Headquarters-
Sector-
Websitegenmab.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
2023 оны 12-р сар
2024 оны 3-р сар
2024 оны 6-р сар
2024 оны 9-р сар
Revenue
4.68 тэрбум
4.14 тэрбум
5.40 тэрбум
5.54 тэрбум
Cost of goods sold
-
-
-
273.00 сая
Cost of revenue
-
-
-
273.00 сая
Research and development expenses
-
-
-
2.28 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
865.00 сая
Operating expense
-
-
-
3.15 тэрбум
Total operating expenses
-
-
-
3.42 тэрбум
Operating income
-
-
-
2.12 тэрбум
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
1.72 тэрбум
EBT excluding unusual items
-
-
-
1.59 тэрбум
Income tax expense
-
-
-
453.00 сая
Effective tax rate
-
-
-
26.35%
Other operating expenses
-
-
-
-
Net income
-
-
-
1.27 тэрбум
Net profit margin
-
-
-
22.85%
Earnings per share
9.67
-
-
19.81
Interest and investment income
-
-
-
162.00 сая
Interest expense
-
-
-
-18.00 сая
Net interest expenses
-
-
-
144.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
2.20 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс